Press release
September 10, 2026
GENFIT to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
SA GENFIT (GNFT)
Lille (France), Cambridge (Massachusetts, United States), September 10, 2026 - GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced that management will participate in the upcoming H.C.